Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

In vitro Mutagenesis

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early access disparities in innovative therapies across the US, EU, China, and Japan.

Frontiers in medicine·2025

Same author

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

The oncologist·2025

Same author

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.

Advances in therapy·2024

Same author

Inflammation, infection, and cardiovascular risk.

Lancet (London, England)·2024

Same author

Case reports as early safety signals: learning from the COVID-19 vaccination campaign.

Frontiers in medicine·2024

Same author

Prioritization of Surgery in Cancer Patients During the COVID-19 Pandemic: Lessons From a Failed Balancing Act.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2023

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Adjuvant activity on human cells in vitro.

Dominique De Wit¹, Michel Goldman

¹Institut d'Immunologie Médicale, Université Libre de Bruxelles, Charleroi, Belgium.

Methods in Molecular Biology (Clifton, N.J.)

|January 26, 2010

Summary

Developing new vaccines requires adjuvants that activate dendritic cells (DCs). This study presents in vitro assays for screening Toll-like receptor (TLR) agonists as potential DC activators for preclinical vaccine development.

Area of Science:

Immunology
Vaccinology
Cell Biology

Background:

Effective vaccines against intracellular pathogens and tumors rely on potent adjuvants.
Adjuvants that activate dendritic cells (DCs) are crucial for vaccine efficacy.
Toll-like receptor (TLR) agonists are promising candidates for DC activation.

Purpose of the Study:

To describe in vitro assays for evaluating dendritic cell (DC) activators.
To facilitate the preclinical screening of novel vaccine adjuvants.
To assess the potential of Toll-like receptor (TLR) agonists.

Main Methods:

Development of in vitro assays using human cells.
Assessment of dendritic cell (DC) activation.
Screening of Toll-like receptor (TLR) agonists.

More Related Videos

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Main Results:

Established reliable in vitro assays for DC activation.
Demonstrated the utility of assays for screening potential adjuvants.
Provided a framework for preclinical assessment of DC activators.

Conclusions:

The described in vitro assays are valuable tools for preclinical vaccine adjuvant screening.
These assays can accelerate the development of novel vaccines targeting intracellular microbes and tumors.
Efficient DC activation is key for developing next-generation vaccines.